Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. [PDF]
Front PharmacolWang TY, Zhang L, Wang HY, Jiang FF.
europepmc +1 more source
Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis. [PDF]
Front Cardiovasc MedYu W +7 more
europepmc +1 more source
Influence of combined eplerenone, aflibercept and nepafenac therapy on central serous chorioretinopathy. [PDF]
Int J OphthalmolEwais WA, Samy Ali L, Aboalazayem F.
europepmc +1 more source
Mineralocorticoid receptor antagonists for acute myocardial infarction: a systematic review and meta-analysis of randomised controlled trials. [PDF]
Open HeartAng SP +7 more
europepmc +1 more source
Sex-Specific Blood Pressure and Brain Microvascular Traits in a Model of Low-Renin Hypertension. [PDF]
HypertensionDe Silva TM +5 more
europepmc +1 more source
Physiologic profiling using plasma renin activity and aldosterone on blood pressure control among Ghanaian stroke survivors: A pilot trial. [PDF]
Equity NeurosciSarfo FS +11 more
europepmc +1 more source
Glomerular Disease and Cystic Kidney Disease: From Pathogenesis to Novel Therapeutic Approaches. [PDF]
BiomedicinesFiliopoulos V.
europepmc +1 more source
Improvement of Peripapillary Pachychoroid Syndrome Following Initiation of Hemodialysis. [PDF]
J Vitreoretin DisAnwarzai Šulavíková Z +2 more
europepmc +1 more source
Comparing the Long-Term Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Versus Mineralocorticoid Receptor Antagonists as Add-On Therapies in the Management of Heart Failure: A Systematic Review. [PDF]
CureusGeorge V +5 more
europepmc +1 more source